PG-011

· Prime Gene Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG-011, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis [Phase 2]

See pricing